211 related articles for article (PubMed ID: 9674732)
1. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.
McWilliam N; Robbie L; Booth N; Bennett B
Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activation in human acute leukaemias.
Scherrer A; Wohlwend A; Kruithof EK; Vassalli JD; Sappino AP
Br J Haematol; 1999 Jun; 105(4):920-7. PubMed ID: 10554801
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an active fibrinolytic system in normal human bone marrow.
McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA
Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456
[TBL] [Abstract][Full Text] [Related]
4. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
5. The Role of Fibrinolytic System in Health and Disease.
Kwaan HC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
[TBL] [Abstract][Full Text] [Related]
6. Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.
Arai Y; Kubota T; Nakagawa T; Kabuto M; Sato K; Kobayashi H
Acta Neurochir (Wien); 1998; 140(4):377-85; discussion 385-6. PubMed ID: 9689330
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
Xiao Y; Bunn CL; Bartold PM
J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of physiological fibrinolysis.
Lijnen HR; Collen D
Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
[TBL] [Abstract][Full Text] [Related]
9. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
Ueyama M; Kasatori N; Urayama T; Maemura T; Yao Y; Shiraishi T; Saito S; Kubo H
Thromb Res; 2002 Nov; 108(4):235-44. PubMed ID: 12617987
[TBL] [Abstract][Full Text] [Related]
11. Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes.
Lee JA; Croucher DR; Ranson M
Thromb Haemost; 2010 Dec; 104(6):1133-42. PubMed ID: 20838737
[TBL] [Abstract][Full Text] [Related]
12. Interference of an activity assay of tissue-type plasminogen activator in human plasma by endogenous factors.
Mukherjee M; Sembhi K; Kakkar VV
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):491-6. PubMed ID: 8840003
[TBL] [Abstract][Full Text] [Related]
13. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
16. Myeloid leukaemic cells can lyse fibrin directly.
Robbie L; Berry S; Moir E; Booth NA; Culligan D; Tighe J; Watson H; King D; Bennett B
Br J Haematol; 2000 Nov; 111(2):524-9. PubMed ID: 11122094
[TBL] [Abstract][Full Text] [Related]
17. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells.
Grimsley PG; Normyle JF; Brandt RA; Joulianos G; Chesterman CN; Hogg PJ; Owensby DA
Thromb Res; 1995 Aug; 79(4):353-61. PubMed ID: 7482438
[TBL] [Abstract][Full Text] [Related]
18. The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.
Kanno Y
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30709025
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
Perides G; Noring R; Klempner MS
Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.
Haj MA; Robbie LA; Croll A; Adey GD; Bennett B
Intensive Care Med; 1998 Mar; 24(3):258-61. PubMed ID: 9565810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
